Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Avicanna Inc (AVCN.TO)

Avicanna Inc (AVCN.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 12,389
  • Shares Outstanding, K 57,624
  • Annual Sales, $ 3,269 K
  • Annual Income, $ -16,775 K
  • 60-Month Beta 2.14
  • Price/Sales 2.33
  • Price/Cash Flow N/A
  • Price/Book 3.18
Trade AVCN.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.34
  • Most Recent Earnings -0.01 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1600 +34.38%
on 06/16/22
0.4000 -46.25%
on 05/31/22
-0.2000 (-48.19%)
since 05/30/22
3-Month
0.1600 +34.38%
on 06/16/22
0.4300 -50.00%
on 04/29/22
-0.1450 (-40.28%)
since 03/30/22
52-Week
0.1600 +34.38%
on 06/16/22
1.0100 -78.71%
on 09/13/21
-0.8650 (-80.09%)
since 06/11/21

Most Recent Stories

More News
Avicanna Sells Stake in Majority-Owned Colombian Subsidiary Sativa Nativa

The company is maintaining operations and its shares in its primary Majority-Owned Subsidiary, Santa Marta Golden Hemp, also based in Santa Marta Colombia...

AVCN.TO : 0.2150 (+2.38%)
AVCNF : 0.1676 (-2.56%)
Avicanna’s Subsidiary Santa Marta Golden Hemp Completes First Commercial Export of Feminized Cannabis Seeds to Lesotho

This export marks the 16th international market entry for Avicanna and the first export of proprietary genetics into Africa. NOT FOR DISTRIBUTION TO...

AVCN.TO : 0.2150 (+2.38%)
AVCNF : 0.1676 (-2.56%)
Stocks in play: Avicanna Inc.

Announced that, through its majority owned Colombian subsidiary, Santa Marta Golden Hemp S.A.S. (“SMGH”), ...

AVCN.TO : 0.2150 (+2.38%)
Avicanna Subsidiary Santa Marta Golden Hemp S.A.S. Completes First Commercial Export of Aureus™ Branded THC and CBD Extracts to Portugal

This export marks Avicanna’s 15th international new market for Avicanna...

AVCN.TO : 0.2150 (+2.38%)
AVCNF : 0.1676 (-2.56%)
Avicanna Reports Q1 2022 Financial Statement and Management Change

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY...

AVCN.TO : 0.2150 (+2.38%)
AVCNF : 0.1676 (-2.56%)
Avicanna Announces Closing of Strategic Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY...

AVCN.TO : 0.2150 (+2.38%)
AVCNF : 0.1676 (-2.56%)
Avicanna Expands RHO PhytoTM Formulary with the Introduction of Cannabigerol (CBG) Products into the Canadian Market

Avicanna introduces the rare cannabinoid CBG into its RHO Phyto product formulary which includes oral, sublingual, and transdermal formulations RHO...

AVCN.TO : 0.2150 (+2.38%)
AVCNF : 0.1676 (-2.56%)
Avicanna Enters into Exclusive License and Supply Agreement with Major South American Pharmaceutical Company

TORONTO, April 13, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical...

AVCN.TO : 0.2150 (+2.38%)
AVCNF : 0.1676 (-2.56%)
Avicanna Expands its Derma-Cosmetics Brand Pura H&W™ into the European Union through a Partnership with Bio-Gate AG

The exclusive distribution agreement includes 5 SKUs from Pura H&W’s evidence-based derma-cosmetics portfolio The products will be commercialized...

AVCN.TO : 0.2150 (+2.38%)
AVCNF : 0.1676 (-2.56%)
Avicanna Announces Filing of Annual Financial Statements for Year Ended December 31, 2021

$3.3M in revenue representing 108% Y-Y growth, significant growth in finished product sales Total of 4 brands, 16 SKU’s and 35 “cannabis...

AVCN.TO : 0.2150 (+2.38%)
AVCNF : 0.1676 (-2.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.2400
2nd Resistance Point 0.2350
1st Resistance Point 0.2250
Last Price 0.2150
1st Support Level 0.2100
2nd Support Level 0.2050
3rd Support Level 0.1950

See More

52-Week High 1.0100
Fibonacci 61.8% 0.6853
Fibonacci 50% 0.5850
Fibonacci 38.2% 0.4847
Last Price 0.2150
52-Week Low 0.1600

See More

Business Summary

Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar